Brief: FDA grants orphan status to Anthera's kidney disease drug

Anthera Pharmaceuticals

09/08/2017 21:00

Aug 10 (Reuters) - Anthera Pharmaceuticals Inc  ANTH.O - 
    * Anthera announces FDA orphan drug designation for 
blisibimod for the treatment of iga nephropathy 
    * Anthera Pharmaceuticals Inc- anthera anticipates 
reporting top-line data later this month for blisibimod 
 
Source text for Eikon:  ID:nGNXOCYVTa  
Further company coverage:  ANTH.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))